tbuckley/cabot-search huggingface dataset:
A Textbook of Clinical Periodontia. A Study of the Causes and Pathology of Periodontal Disease and a Consideration of Its Treatment.
Authors: Paul Roscoe Stillman
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
An autologous platelet-rich plasma hydrogel compound restores left ventricular structure, function and ameliorates adverse remodeling in a minimally invasive large animal myocardial restoration model: A translational approach
Authors: Thang Duc Vu, Shripad N Pal, Lian-Kah Ti, Eliana C Martinez, Abdul Jalil Rufaihah, Lieng H Ling, Chuen-Neng Lee, Arthur Mark Richards, Theo Kofidis
Journal: Biomaterials (2015)
Prognosis in Musculoskeletal Injury: A Handbook for Doctors and Lawyers
Authors: Eurig Jeffreys
Journal: Annals of Internal Medicine (1991)

Part 1 The spine and pelvis: injuries to the vertebral column fractures of the cervical spine soft tissue injuries of the cervical spine fractures of the pelvis. Part 2 The upper limb: dislocation of the sternoclavicular joint fractures of the clavicle dislocation of the acromioclavicular joint acute tears of the rotator cuff anterior dislocation of the shoulder joint posterior dislocation of the shoulder fractures of the neck of the humerus fractures of the shaft of the humerus fractures of the lower end of the humerus in adults supracondylar fractures of the humerus in children fractures of the lateral humeral condyle in children displacement of the epiphysis of the medical epicondyle injuries around the elbow fractures of the olecranon fractures of the head of the radius dislocation of the elbow (in adults) fractures of the upper radial epiphysis dislocation of the elbow in children fractures of radius and ulna (in adults) fracture of the shaft of the ulna with dislocation of the superior radio-ulnar joint fracture of the shaft of the radius with inferior radio-ulnar dislocation fractures of the shaft of the ulna fractures of both bones of the forearm in children colles' fracture anterior displacement of the lower radius - Smith's and Barton's fractures displacement of the lower radial epiphysis fractures of the scaphoid fractures, dislocations and fracture dislocations of the corpus hand injuries overuse syndromes in the upper limb. Part 3 The lower limb: dislocations of the hip central fracture dislocation of the hip fractures of the neck of the femur slipped upper femoral epiphysis subtrochanteric fractures of the femur fractures of the shaft of the femur fractures of the femoral condyles fractures of the lower femoral epiphysis dislocation of the kne ruptures of the quadriceps tendon injuries of the patellar ligament fractures and dislocations of the patella injuries of the menisci injuries of the ligaments of the knee fractures of the condyles of the tibia fractures of the shaft of the tibia fractures of the ankle rupture of the lateral ligament of the ankle rupture of hte achilles tendon fractures and fracture dislocations of the talus fractures of the calcaneum midtarsal injuries fracture and fracture dislocations of the tarsometatarsal joints fractures of the fifth metatarsal injuries of the forefoot.
Preliminary results of a multicenter randomized phase II trial of two different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)
Authors: M. Rinaldi, S. Novello, I. Bernardini, L. Crinò, M. Nardi, F. de Marinis, M. Tonato, C. Sguotti, L. Marini, G. V. Scagliotti
Journal: Journal of Clinical Oncology (2005)

7124 Background: Cisplatin remains the cornerstone in the treatment of advanced NSCLC, but the optimal sequencing of drugs and the role of non-cisplatin doublets remains to be defined. The aim of this phase II trial was to evaluate the response rate of two different schedules of D and G and of a third arm of GC followed by D. Secondary end points included toxicity, progression-free and overall survival. Methods: Chemotherapy-naive stage IIIB (N3 or T4 pleural)/IV NSCLC patients (pts), ECOG PS 0–1, age 18–70 yrs received (Arm A) D (40mg/m2 days 1–8) and G (1200mg/m2 days 1–8) every 21 days, or (Arm B) D (50mg/m2; days 1–15) and G (1500mg/m2 days 1–15) every 28 days, both for a maximum of 6 cycles, or (Arm C) G (1200mg/m2 days 1–8) and C (75 mg/m2 day 2) for 3 cycles followed, in case of stable disease (SD), partial response (PR) or complete response (CR) by D (75 mg/m2 day 1) for 3 cycles, both every 21 days. Results: From July 2002 to May 2004, 128 pts were enrolled (41 in Arm A; 46 in Arm B; 41 in Arm C). Pts characteristics were well balanced in all arms: overall median age 61 yrs, PS 0 in 52%, stage IIIB in 19% of pts. Among 123 pts analyzed, a total of 512 cycles (range 1–6) has been globally administered in the three arms and 76% of pts completed 3 cycles. Toxicity (by cycles) according to WHO criteria, was mainly hematological, consisting of grade 3–4 neutropenia in 86 (17%) cycles (16/25/45) with less than 1% of febrile neutropenia and grade 3 thrombocytopenia in 19 (4%) cycles (6/2/11). Anemia g3–4 was present only in arm C in 5 cycles (1%). Non-hematologic toxicity was very mild and without consistent differences among the three arms: gastrointestinal g3–4 in 7 (1%) cycles, asthenia g3 in 18 (4%) cycles, neurological g3 in 8 (2%) cycles and skin toxicity g3 in 3 (<1%) cycles. Currently response rate (PR/SD/PD) at cycle 3 was centrally reviewed in 111 pts (28 in arm A, 27 in arm B, 56 in arm C): 9 PR (32%)/7 SD/9 PD in arm A, 8 PR (30%)/9 SD/9 PD in arm B and 22 PR (39%)/17 SD/7 PD in Arm C. Conclusions: Preliminary efficacy data show a comparable level of activity for all three arms and a manageable toxicity. Author Disclosure Employment or Leadership Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration Eli Lilly Italy, sanofi-aventis
How should different life expectancies be valued?
Authors: T. Benson, W. Brouwer, B. van Hout
Journal: BMJ (1998)

Editor—Problems with the valuation of life expectancy and quality adjusted life years1 can be traced to the underlying philosophical paradigm. The quality adjusted life year paradigm is based on 19th century classical utilitarianism. The greatest good is perfect health, which is valued at 1; being dead (and the event of death) has the value of 0. Other states are given values of <1; states judged worse than death may be given negative values.2
Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus
Authors: J. S. Skyler, D. Brown, H. P. Chase, E. Collier, C. Cowie, G. S. Eisenbarth, J. Fradkin, G. Grave, C. Greenbaum, R. A. Jackson, F. R. Kaufman, J. P. Krischer, J. B. Marks, J. P. Palmer, A. Ricker, D. A. Schatz, D. Wilson, W. E. Winter, J. Wolfsdorf, A. Zeidler, H. Dickler, R. C. Eastman, N. K. Maclaren, J. I. Malone, P. R. Robertson, D. Cuthbertson, L. M. Rafkin-Mervis, K. Herold, L. Rafkin-Mervis, B. Aneju, D. Conboy, R. Cook, M. A. Dennis, L. Finney, S. Harris, D. Matheson, M. McCulloch-Olsen, T. Smith, J. Valenzuela, N. Vega, O. B. Crofford, D. DeMets, J. M. Lachin, A. Rossini, A. Schiffrin, M. Steffes, A. Tsiatis, B. Zinman
Journal: New England Journal of Medicine (2002)

It is unknown whether insulin therapy can delay or prevent diabetes in nondiabetic relatives of patients with diabetes.
Abstract 562: Improvement In Left Ventricular Function Due To A Reduction Of Myocardial Fibrosis Following Myocardial Infarction Using A Purpose Designed Novel Anti Fibrotic Drug FT-011
Authors: Maros Elsik, Yuan Zhang, Bing Wang, Andrew Kompa, Richard Gilbert, Henry Krum, Darren Kelly
Journal: Circulation (2007)

Introduction: Following myocardial infarction (MI), pathological deposition of excess collagen adversely effects cardiac function. We evaluated the role of a novel anti-fibrotic drug FT-011 (Fibrotech, Australia) in preventing fibrosis and preserving ventricular function. Methods : To first test for anti-fibrotic effects, isolated rat neonatal cardiac fibroblasts were stimulated with angiotensin II (AII)(0.1 μmol/L) or TGF-ß(10ng/ml) and treated with FT-011 (30–200 μmol/L) alone or in combination with the angiotensin II antagonist irbesartan (Irb)(10 −5 -10 −7 mmol/l). Effects on collagen synthesis were assessed by 3 H-proline incorporation. Subsequently, ten week old Sprague Dawley rats underwent LAD artery ligation to induce MI (or sham procedure), then treatment for 4 weeks with FT-011(200 mg/kg/d) or vehicle, starting 1 week post surgery. Left ventricular (LV) function was assessed by echocardiography (day 2 and 35 post-surgery) and cardiac catheterization (day 35). Total collagen (TC) deposition (by picrosirius red staining) and collagen subtypes I and III (C-I, C-III, by immunohistochemistry) were assessed. Results: A dose dependent reduction of collagen synthesis with FT-011 in response to both AII or TGF-ß stimulation (p&lt;0.01), and a further reduction with FT-011±Irb was observed in vitro. In vivo, MIs were of comparable size. Treatment with FT-011 significantly reduced TC, C-I and C-III (p&lt;0.05) in the myocardium, resulting in improved LV systolic function, normalization of diastolic function parameters (Table ) and improvement in heart failure with a reduction in lung/body weight ratio with FT-011 (p&lt;0.05). Table: 35 day data [mean (SEM)]. Conclusion: Post MI treatment with FT-011 improved heart function by reducing pathological remodeling of the ventricle. This appears to be occurring at least in part via a direct anti-fibrotic effect of the drug.
Abstract 4169: Defining Myocardial Injury and Function Following Coronary Artery Bypass Grafting: Insights From Serial Cardiovascular Magnetic Resonance Imaging and Biochemical Assessment
Authors: Tammy J Pegg, Zoe Maunsell, Jane Francis, Theodoros Karamitsos, Stefan Neubauer, David Taggart, Joseph Selavanayagam
Journal: Circulation (2009)
The Suppression of Tuberculosis, Together with Observations Concerning Phthisiogenesis in Man and Animals and Suggestions Concerning the Hygiene of Cow Stables and the Production of Milk for Infant Feeding, with Special Reference to Tuberculosis.
Authors: Emil von Behring, Bolduan, Charles, b.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 14430: Outcomes in Advanced Heart Failure with Left Ventricular Assist Devices for Destination Therapy
Authors: Soon J Park, Carmelo A Milano, Antone J Tatooles, Joseph G Rogers, Robert M Adamson, D E Steidley, Gregory A Ewald, David J Farrar, Mark S Slaughter
Journal: Circulation (2010)

Background: The initial HeartMate (HM) II LVAD Destination Therapy (DT) trial demonstrated significant improvements in outcomes compared to patients with pulsatile flow LVADs. Since then, additiona...
Bacterial Infections. Changes in Their Causative Agents, Trends and Possible Basis.
Authors: Maxwell Finland, Walter Marget, K. Bartmann
Journal: Annals of Internal Medicine (1972)

Welcome.- I. Bacterial Infections: Changes in their Causative Agents. Trends.- Changing Prevalence of Pathogenic Bacteria in Relation to Time and the Introduction and Use of New Antimicrobial Agents.- Discussion.- The Changing Pattern of Infecting Organisms.- Etiology of Pyogenic and Urinary Tract Infections in the Region of Cologne.- The Change of Causative Agents in Wound Infection, Septicaemia and Meningitis in a 2000-bed Hospital from 1957 to 1968.- Discussion.- Distribution of Pneumococcus Types at Different Times in Different Areas.- Discussion.- II. Bacterial Infections: Changes in their Causative Agents. Possible Basis.- Non-Specific Mechanisms of Resistance to Infection and their Influence on the Changing Pattern of Causative Agents.- Discussion.- Opportunists and Opportunity in Infection.- Discussion.- The Colonisation of Ventriculo-Atrial Shunts by Coagulase-Negative Staphylococci.- Discussion.- Pathogenic Significance of Coagulase-Negative Staphylococci.- Discussion.- Changes in the Virulence and Antibiotic Resistance of Staphylococcus aureus.- Pool of Staphylococcal Infections in a Hospital.- Discussion.- Changes of the Infectious Pool in the Hospital with Regard to Pseudomonas aeruginosa and Escherichia coli.- Discussion.- Occurrence of Serratia marcescens in Soft Tissue Infections.- Discussion.- Septic Infections by Bacteria of low Pathogenicity in Patients with Resistance Reduced by Chemotherapy.- Discussion.- Influence of Antibiotic Treatment on the Bacterial Flora of Severe Burns.- Discussion.- An Antibody Response in Pyelonephritis after Change in Causative Organisms.- Discussion.- L-Forms: Problems and Outlook.- Role of Deficient Mutants in Microbial Persistence.- Discussion.- Epidemiological Investigations of R-Factor Bearing Enterobacteriaceae in Man and Animals in Germany.- Discussion.- General Discussion.- Author Index.
A METHOD FOR DESCRIBING TRAFFIC AND THE TRAFFIC SAFETY SITUATION RELATING TO GCM (PEDESTRIANS, CYCLISTS AND MOPED RIDERS) ROAD USERS
Authors: H Thulin
Journal: BMJ (1984)

The report describes road users' (pedestrians, cyclists and moped riders) safety in traffic. The survey method is presented and applied. Traffic flow, traffic composition and degree of separation between pedestrians, cyclists, moped riders and motor vehicles have been studied as well as the relationship between accidents and separation. The survey was performed by video or by manual recording in an urban area during five days. (TRRL)
Treatment of VHL patients with sunitinib: Clinical observations and translational studies
Authors: S. F. Matin, I. E. McCutcheon, D. S. Gombos, S. G. Waguespack, S. Wen, L. A. Smith, Y. Zhang, D. W. Davis, G. Fuller, E. Jonasch
Journal: Journal of Clinical Oncology (2009)

e22047 Background: Von Hippel Lindau (VHL) disease induces vascular lesions in multiple organs. Surgical intervention is the treatment of choice. Effective, safe systemic therapy will greatly improve the quality of life of these individuals. Methods: Patients with genetically confirmed VHL were enrolled on an IRB approved trial. Eligibility criteria included retinal angiomas, hemangioblastomas (HBs) measuring at least 5mm, renal cell carcinoma (RCC) 1 to 3 cm and pancreatic neuroendocrine tumors (NETs) 1 to 3 cm. Patients received sunitinib 50mg/day for 28 days/14 days off for four cycles. Scans were performed at baseline, and after cycles two and four. A separate set of 20 formalin-fixed paraffin embedded HBs and 20 RCCs were used for laser scanning cytometry (LSC) analysis of total and phospho vascular endothelial growth factor receptor (pVEGFR) and phospho platelet derived growth factor receptor (pPDGFR) levels in tumor endothelium. Results: Twelve patients were evaluable for response and toxicity. Eight had RCCs, nine had CNS lesions, and three had pancreatic NETs. Tumor size reduction was seen in 16/19 evaluable RCC lesions (95%CI 0.60, 0.97), 3/5 NETs (95%CI 0.15, 0.95) and 6/19 HBs (95%CI 0.13, 0.57). Two patients came off study for treatment related side effects, one patient progressed on study, and two patients did not complete the scheduled course of therapy. LSC analysis demonstrated significantly lower phospho VEGFR levels in HBs when compared with RCC. The mean (SD) of pVEGFR levels in log-transformation were 11.27 (0.49) and 11.75 (0.37) for HBs and RCC respectively (p = 0.003). The mean (SD) of pVEGFR to VEGFR ratio was .21 (0.12) versus 0.37 (0.43), for HBs and RCC respsectively (p = 0.043). Conclusions: Sunitinib treatment of patients with VHL resulted in consistent decrease of RCC and NET tumor size. The discrepant response to sunitinib in RCC and HBs may be explained by differential dependence on VEGFR activation in tumor endothelium. [Table: see text]
Pagan and Christian mysteries; papers from the Eranos yearbooks.
Authors: Joseph Campbell, Ralph Manheim, R. F. C. Hull
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Analysis of serum phospholipid-fatty acid and antioxidant system in patients with cervical intraepithelial neoplasia and cervical cancer
Authors: H. Y. Kim, J. W. Kim, Y. T. Kim, E. S. Kim, S. Y. Kim, Y. J. Shim, Y. S. Ko, B. S. Yoon, Y. J. Lee
Journal: Journal of Clinical Oncology (2006)

15068 Background: The membrane compositions, especially phospholipid-fatty acid (PL-FA) and antioxidant system have been focused on carcinogenesis. Therefore, the objective was to examine the patterns of PL-FA and antioxidant status in patients with cervical intraepithelial neoplasia (CIN) and invasive cervical cancer. Methods: Blood samples were obtained from 23 patients diagnosed as invasive cervical cancer, 32 with CIN and 41 with other benign gynecologic diseases as the control group. Compositions of serum PL-FAs, total antioxidant performance (TAP), and lipid peroxidation were assessed and compared between these 3 groups. Serum levels of PL-FAs were analyzed by the GC system, after extracting phospholipids using Folch and TLC methods. Fluorometer were used to measure lipid-soluble radical for assessment of TAP and serum malondialdehyde (MDA) was quantified to evaluate the degree of lipid peroxidation. Results: With the highest proportion of saturated fatty acids (SFAs), polyunsaturated fatty acids (PUFAs)/SFAs ratio was lowest in the invasive cervical cancer group. While the EPA (eicosapentaenoic acid, C20:5ω3) + DHA (docosapentaenoic acid, C22:6ω3)/linolenic acid (C18:3ω3) ratio (ω3 product/ω3 precursor) was significantly lower in the CIN group (p &lt; 0.0001), arachidonic acid (C20:4ω6)/linoleic acid (C18:2ω6) ratio (ω6 product/ω6 precursor) tended to be higher in patients with CIN and cervical cancer (p = 0.0682). In w6 series fatty acids, consistent trends of higher desaturation indices and lower enlongation indices were observed in CIN and invasive cervical cancer groups. The level of MDA was significantly higher in cervical cancer group than in CIN and control groups. The value of TAP was significantly lower in CIN. Conclusions: In patients with cervical neoplasia, the endogenous production of DHA and EPA, as well as ω3 derivatives seems to be decreased. Since cervical cancer patients displayed higher MDA levels and lower TAP, antioxidant status also tends to be lower in this group. These significant changes in patterns of PL-FAs and antioxidant status in cervical cancer patients suggest their possible involvements in carcinogenesis, but further studies are mandatory to define the exact causal relationship. No significant financial relationships to disclose.
An outbreak of mumps in Sweden, February-April 2004
Authors: B Sartorius, P Penttinen, J Nilsson, K Johansen, K Jönsson, M Arneborn, M Löfdahl, J Giesecke
Journal: Eurosurveillance (2005)

Between 24 February and 26 April 2004, Västra Götaland county in Sweden reported 42 cases of suspected mumps. A descriptive study of the cases was undertaken. A questionnaire was administered by telephone and vaccine effectiveness was calculated using the screening method. Seventy four per cent (31/42) of the suspected cases were interviewed by telephone. Eight out of the 42 serum samples were positive or equivocal for mumps IgM by ELISA. Mumps virus genome was identified in 21/42 (50%) saliva samples. Eleven were selected for sequencing and all were confirmed to be mumps virus. Cases were predominantly from 2 small towns. Eighteen out of 19 cases that developed bilateral swelling could be linked to one small town. The median age of interviewed cases was 43 years (range 5 to 88). Six cases were admitted to hospital, 5 of which were older than 30 years. The highest incidence occurred in the 35 to 44 years age group. Vaccine effectiveness was estimated to be 65% for 1 dose and 91% for 2 doses. This descriptive study shows the increasing age of mumps cases with increasing vaccine coverage. Vaccine effectiveness was particularly high for 2 doses. Second-dose uptake must be ensured, as primary vaccine failure is well documented in mumps. Stronger precautions must be taken to avoid pools of susceptible older individuals accumulating due to the increased risk of complications.
Abstract 14989: Impact of Chronic Kidney Disease on Coronary Atherosclerotic Plaque in Patients with Metabolic Syndrome
Authors: Ayako Kunimura, Tetsuya Amano, Kazuhiro Harada, Katsuhide Kitagawa, Yusaku Shimbo, Akihiro Suzuki, Hirohiko Ando, Ken Harada, Tomohiro Yoshida, Bunichi Kato, Tadayuki Uetani, Masataka Kato, Nobuyuki Marui, Michio Nanki, Hideki Ishii, Tatsuaki Matsubara, Toyoaki Murohara
Journal: Circulation (2011)

Background: Chronic kidney disease (CKD) has emerged as a major atherosclerotic risk factor and is associated with metabolic syndrome. However, synergistic effects of these two risk factors on coro...